We found that most SUZ12 targets in hepatocellular carcinoma and embryonic fibroblast, including EPCAM, IGFII, DKK1, HEY2, CCNA1, CCND2, DAB2IP, BMP6, PAX4, DLX5, LHX1, NEFL, NEUROG1, NEUROG2, NMU, SHH, showed little expression change in our PCa cell microarray data when treated by DHT; meanwhile, BAMBI and MASS1 targeted by SUZ12 are down-regulated. Here, NMU is linked to posterior cortical atrophy.